Showing results (1941-1950 of 2,138) with videos related to
Sort By:
Pageof 214
Cancer|January 19, 2023
Psychological mobile app for patients with acute myeloid leukemia: A pilot randomized clinical trialAreej El-Jawahri, Marlise R Luskin, Joseph A Greer, et al.Leukemia|November 16, 2016
Mutations in the CCND1 and CCND2 genes are frequent events in adult patients with t(8;21)(q22;q22) acute myeloid leukemiaA-K Eisfeld, J Kohlschmidt, S Schwind, et al.Nature Medicine|February 14, 2017
The creatine kinase pathway is a metabolic vulnerability in EVI1-positive acute myeloid leukemiaNina Fenouille, Christopher F Bassil, Issam Ben-Sahra, et al.Cancer Immunology Research|November 7, 2018
Phase I Trial of Autologous CAR T Cells Targeting NKG2D Ligands in Patients with AML/MDS and Multiple MyelomaSusanne H Baumeister, Joana Murad, Lillian Werner, et al.Leukemia|April 11, 2008
Dasatinib induces durable cytogenetic responses in patients with chronic myelogenous leukemia in chronic phase with resistance or intolerance to imatinibA Hochhaus, M Baccarani, M Deininger, et al.Journal of Hematology & Oncology|June 24, 2021
A precision medicine classification for treatment of acute myeloid leukemia in older patientsAlice S Mims, Jessica Kohlschmidt, Uma Borate, et al.Leukemia|July 20, 2024
Subunit-specific analysis of cohesin-mutant myeloid malignancies reveals distinct ontogeny and outcomesJohann-Christoph Jann, Christopher B Hergott, Marisa Winkler, et al.Human Molecular Genetics|October 24, 2015
Hypomorphic mutations in TRNT1 cause retinitis pigmentosa with erythrocytic microcytosisAdam P DeLuca, S Scott Whitmore, Jenna Barnes, et al.Blood|January 1, 2015
Acute myeloid leukemia ontogeny is defined by distinct somatic mutationsR Coleman Lindsley, Brenton G Mar, Emanuele Mazzola, et al.Blood Advances|July 12, 2021
Phase 3 randomized trial of chemotherapy with or without oblimersen in older AML patients: CALGB 10201 (Alliance)Alison R Walker, Guido Marcucci, Jun Yin, et al.Pageof 214